ArticleLeukemia2017
Combined STAT3 and BCR-ABL1 inhibition induces synthetic lethality in therapy-resistant chronic myeloid leukemia.
A M Eiring et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
16 papers cite it
this papercites it
ArticleLeukemia2017
A M Eiring et al.PubMed ↗Publisher ↗
No numbers read from the abstract.